Mylan must hand over authorised generic docs ahead of injunction hearing

Ashurst 2019-03-25 8:29 pm By Miklos Bolza | Sydney

Please login to bookmark

Pharmaceutical giant Mylan has been ordered to hand over documents relating to its proposed launch of a generic version of its cholesterol drug Lipidil to rival Sun Pharma in advance of a hearing on Mylan’s request for an order blocking Sun from launching its own generic version of the drug.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au